Add BrightSurf on Google Email

University of Pennsylvania School of Medicine


Study reveals novel use of 3-D imaging for measurement of injectable wrinkle reducers

Researchers developed a novel method to measure injectable wrinkle reducer efficacy using 3D imaging. The technique, called speckle tracking photogrammetry, allows for objective evaluation of wrinkle reduction and optimal dosage. It has the potential to guide physician and consumer choice in individual cases.

SourceUniversity of Pennsylvania School of Medicine·JournalPlastic & Reconstructive Surgery·DateMay 27, 2015

Penn Medical School dean: Precision medicine is 'personalized, problematic, and promising'

The rapidly emerging field of precision medicine is characterized by its use of genetic, biomarker, and psychosocial characteristics to tailor treatments for individual patients. While it holds great promise, precision medicine also raises concerns about the balance between patient needs and fiscal management.

SourceUniversity of Pennsylvania School of Medicine·JournalNew England Journal of Medicine·DateMay 27, 2015

Penn study links better 'good cholesterol' function with lower risk of later heart disease

A large prospective study found that individuals with higher HDL function have a lower risk of developing coronary heart disease. Researchers from the University of Pennsylvania analyzed data from over 25,000 participants and discovered a strong correlation between HDL function and reduced heart disease events.

SourceUniversity of Pennsylvania School of Medicine·JournalThe Lancet Diabetes & Endocrinology·DateMay 26, 2015

Giving HOPE: US has nearly 400 HIV-positive potential organ donors

A study published in the American Journal of Transplantation found that there are nearly 400 HIV-positive potential organ donors in the US who could provide life-saving organs for HIV-positive patients. The study estimates that these donors could reduce the waiting time for transplants, but the quality of their organs is a concern.

SourceUniversity of Pennsylvania School of Medicine·JournalAmerican Journal of Transplantation·DateMay 14, 2015

Gene therapy efficacy for LCA: Improvement is followed by decline in vision

A new study demonstrates that gene therapy for Leber congenital amaurosis (LCA) improves vision in patients within weeks of treatment, with benefits peaking at one to three years after treatment. However, the visual gain eventually declines, highlighting the need for future therapeutic strategies to sustain restored vision.

SourceUniversity of Pennsylvania School of Medicine·JournalNew England Journal of Medicine·DateMay 3, 2015

Penn researcher advises translational med hubs best place for clinical phenotyping efforts

The article highlights the importance of clinical phenotyping in precision medicine, with Penn researcher Garret FitzGerald advocating for translational med hubs to be equipped with the necessary resources. The NIH's Clinical and Translational Science Awards (CTSAs) program is seen as a key driver of this effort.

SourceUniversity of Pennsylvania School of Medicine·JournalScience Translational Medicine·DateApr 22, 2015

Messenger RNA-associated protein drives multiple paths in T-cell development

A new study found that an increase in CELF2 expression drives widespread changes in mRNA splicing during T-cell development, leading to physiologically important changes in proteins. The research provides unprecedented insight into the regulation of splicing during thymic development and reveals a biologic role for CELF2 in human T cells.

SourceUniversity of Pennsylvania School of Medicine·JournalProceedings of the National Academy of Sciences·DateApr 21, 2015

Penn Medicine pain management study reveals patient confusion about opioid addiction

A new Penn Medicine study found that patients seen in emergency departments have misperceptions about opioid dependence and want more information about their pain management options. Patients desire better communication from physicians about their pain management options, along with discussion of the risks of opioid dependence.

SourceUniversity of Pennsylvania School of Medicine·JournalAnnals of Emergency Medicine·DateApr 13, 2015

Roseroot herb shows promise as potential depression treatment option, Penn team finds

A study led by the University of Pennsylvania found that roseroot extract may be an effective treatment for mild to moderate major depressive disorder, with fewer side effects than conventional antidepressants. The herbal remedy showed a more favorable risk-to-benefit ratio, suggesting its potential as an alternative therapy option.